These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10224387)

  • 1. Clinical testing of recombinant allergens of the mold Alternaria alternata.
    Unger A; Stöger P; Simon-Nobbe B; Susani M; Crameri R; Ebner C; Hintner H; Breitenbach M
    Int Arch Allergy Immunol; 1999; 118(2-4):220-1. PubMed ID: 10224387
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives.
    Pauli G; Purohit A; Oster JP; de Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):216-7. PubMed ID: 10224385
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
    Vrtala S; Hirtenlehner K; Susani M; Hufnagl P; Binder BR; Vangelista L; Pastore A; Sperr WR; Valent P; Ebner C; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):218-9. PubMed ID: 10224386
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific immunotherapy, one century later.
    Passalacqua G; Bush RK
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic engineering of allergens: future therapeutic products.
    Ferreira F; Wallner M; Breiteneder H; Hartl A; Thalhamer J; Ebner C
    Int Arch Allergy Immunol; 2002 Jul; 128(3):171-8. PubMed ID: 12119498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of molecular biology on allergen immunotherapy.
    Bush RK
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant allergens.
    Valenta R; Vrtala S; Laffer S; Spitzauer S; Kraft D
    Allergy; 1998 Jun; 53(6):552-61. PubMed ID: 9689336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective of purified natural and recombinant allergens in diagnosis and treatment of inhalant allergies.
    van Ree R; van Leeuwen A; Bond J; Aalberse R
    Int Arch Allergy Immunol; 1999; 118(2-4):212-3. PubMed ID: 10224383
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular characterization of Alternaria alternata and Cladosporium herbarum allergens.
    Achatz G; Oberkofler H; Lechenauer E; Simon B; Unger A; Kandler D; Ebner C; Prillinger H; Kraft D; Breitenbach M
    Adv Exp Med Biol; 1996; 409():157-61. PubMed ID: 9095236
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-tailored recombinant allergen products--mission impossible?
    Cromwell O; Matricardi PM; Fiebig H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():210-7; discussion 217-8. PubMed ID: 20799463
    [No Abstract]   [Full Text] [Related]  

  • 14. The allergens of Cladosporium herbarum and Alternaria alternata.
    Breitenbach M; Simon-Nobbe B
    Chem Immunol; 2002; 81():48-72. PubMed ID: 12102004
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergies.
    Kraft D; Ferreira F; Vrtala S; Breiteneder H; Ebner C; Valenta R; Susani M; Breitenbach M; Scheiner O
    Int Arch Allergy Immunol; 1999; 118(2-4):171-6. PubMed ID: 10224369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological standardization and maximum tolerated dose estimation of an Alternaria alternata allergenic extract.
    Lizaso MT; Martínez A; Asturias JA; Algorta J; Madariaga B; Labarta N; Tabar AI
    J Investig Allergol Clin Immunol; 2006; 16(2):94-103. PubMed ID: 16689182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant allergens for specific immunotherapy.
    Valenta R; Vrtala S
    Allergy; 1999; 54 Suppl 56():43-4. PubMed ID: 10532305
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens.
    Asturias JA; Ibarrola I; Ferrer A; Andreu C; López-Pascual E; Quiralte J; Florido F; Martínez A
    J Allergy Clin Immunol; 2005 Jun; 115(6):1210-7. PubMed ID: 15940136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alt a 15 is a new cross-reactive minor allergen of Alternaria alternata.
    Gabriel MF; Postigo I; Gutiérrez-Rodríguez A; Suñén E; Guisantes JA; Fernández J; Tomaz CT; Martínez J
    Immunobiology; 2016 Feb; 221(2):153-60. PubMed ID: 26395961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering allergens.
    Mutschlechner S; Ferreira F
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):226-9. PubMed ID: 17124778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.